D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 26 (6) , 641-644
- https://doi.org/10.1016/0028-3908(87)90160-2
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responsesBrain Research, 1987
- Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393Psychopharmacology, 1986
- Effect of dopamine system activation on substantia nigra pars reticulata output neurons: variable single-unit responses in normal rats and inhibition in 6-hydroxydopamine-lesioned ratsJournal of Neuroscience, 1984
- Effects of dopamine depletion on rotational behavior to dopamine agonistsBrain Research, 1983
- THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISMJournal of Neurochemistry, 1978
- Bromocriptine in ParkinsonismArchives of Neurology, 1978
- Interaction of Ergot Drugs with Central Monoamine SystemsPharmacology, 1978
- Treatment of Parkinson's Disease with BromocriptineNew England Journal of Medicine, 1976
- Bromocriptine treatment in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1976
- STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPABritish Journal of Pharmacology, 1976